CN108785748A - A kind of Multifunctional heart blood vessel coating material and preparation method thereof with super hydrophilicity - Google Patents
A kind of Multifunctional heart blood vessel coating material and preparation method thereof with super hydrophilicity Download PDFInfo
- Publication number
- CN108785748A CN108785748A CN201810731279.9A CN201810731279A CN108785748A CN 108785748 A CN108785748 A CN 108785748A CN 201810731279 A CN201810731279 A CN 201810731279A CN 108785748 A CN108785748 A CN 108785748A
- Authority
- CN
- China
- Prior art keywords
- coating material
- preparation
- final concentration
- acid
- multifunctional cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 63
- 239000011248 coating agent Substances 0.000 title claims abstract description 62
- 239000000463 material Substances 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 210000004204 blood vessel Anatomy 0.000 title abstract description 6
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract description 44
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims abstract description 28
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims abstract description 28
- 239000007853 buffer solution Substances 0.000 claims abstract description 21
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960003638 dopamine Drugs 0.000 claims abstract description 14
- -1 polyphenol compounds Chemical class 0.000 claims abstract description 12
- 239000008367 deionised water Substances 0.000 claims abstract description 11
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 7
- 229910001873 dinitrogen Inorganic materials 0.000 claims abstract description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 18
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 14
- 239000000872 buffer Substances 0.000 claims description 12
- 239000012620 biological material Substances 0.000 claims description 8
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims description 7
- 235000004515 gallic acid Nutrition 0.000 claims description 7
- 229940074391 gallic acid Drugs 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 claims description 6
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 claims description 5
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims description 5
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 5
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 claims description 5
- 235000012734 epicatechin Nutrition 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 4
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims description 4
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 claims description 4
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 4
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 claims description 3
- 229910010293 ceramic material Inorganic materials 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 claims description 3
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims description 3
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims description 3
- 239000007769 metal material Substances 0.000 claims description 3
- LRWJZGCOPMDWFZ-UHFFFAOYSA-N phthalic acid;hydrochloride Chemical compound Cl.OC(=O)C1=CC=CC=C1C(O)=O LRWJZGCOPMDWFZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002861 polymer material Substances 0.000 claims description 3
- 229940079877 pyrogallol Drugs 0.000 claims description 3
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 claims description 3
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 claims description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 2
- SNKFFCBZYFGCQN-UHFFFAOYSA-N 2-[3-[3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyloxy]-3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound C=1C=C(O)C=2OC(C=3C=C(O)C(O)=CC=3)C(C(=O)OC(CC=3C=C(O)C(O)=CC=3)C(O)=O)C=2C=1C=CC(=O)OC(C(=O)O)CC1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-UHFFFAOYSA-N 0.000 claims description 2
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 claims description 2
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 2
- 229920002079 Ellagic acid Polymers 0.000 claims description 2
- 239000001263 FEMA 3042 Substances 0.000 claims description 2
- SNKFFCBZYFGCQN-VWUOOIFGSA-N Lithospermic acid B Natural products C([C@H](C(=O)O)OC(=O)\C=C\C=1C=2[C@H](C(=O)O[C@H](CC=3C=C(O)C(O)=CC=3)C(O)=O)[C@H](OC=2C(O)=CC=1)C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 SNKFFCBZYFGCQN-VWUOOIFGSA-N 0.000 claims description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 2
- 229930002877 anthocyanin Natural products 0.000 claims description 2
- 235000010208 anthocyanin Nutrition 0.000 claims description 2
- 239000004410 anthocyanin Substances 0.000 claims description 2
- 150000004636 anthocyanins Chemical class 0.000 claims description 2
- 235000004132 ellagic acid Nutrition 0.000 claims description 2
- 229960002852 ellagic acid Drugs 0.000 claims description 2
- 229930003935 flavonoid Natural products 0.000 claims description 2
- 150000002215 flavonoids Chemical class 0.000 claims description 2
- 235000017173 flavonoids Nutrition 0.000 claims description 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 2
- QTYWBJZOZDYCGB-UHFFFAOYSA-L potassium;sodium;2-carboxybenzoate;hydroxide Chemical compound [OH-].[Na+].[K+].OC(=O)C1=CC=CC=C1C([O-])=O QTYWBJZOZDYCGB-UHFFFAOYSA-L 0.000 claims description 2
- STCJJTBMWHMRCD-UHFFFAOYSA-N salvianolic acid B Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)C=Cc2cc(O)c(O)c3OC(C(C(=O)OC(Cc4ccc(O)c(O)c4)C(=O)O)c23)c5ccc(O)c(O)c5 STCJJTBMWHMRCD-UHFFFAOYSA-N 0.000 claims description 2
- HXMWJLVXIHYART-UHFFFAOYSA-M sodium;2-hydroxypropane-1,2,3-tricarboxylic acid;hydroxide;hydrochloride Chemical compound [OH-].[Na+].Cl.OC(=O)CC(O)(C(O)=O)CC(O)=O HXMWJLVXIHYART-UHFFFAOYSA-M 0.000 claims description 2
- 235000015523 tannic acid Nutrition 0.000 claims description 2
- 229920002258 tannic acid Polymers 0.000 claims description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 2
- 229940033123 tannic acid Drugs 0.000 claims description 2
- 238000004506 ultrasonic cleaning Methods 0.000 claims description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims 2
- ADZHXBNWNZIHIX-XYGAWYNKSA-N cyanidin 3-O-rutinoside chloride Chemical compound [Cl-].O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(=[O+]C3=CC(O)=CC(O)=C3C=2)C=2C=C(O)C(O)=CC=2)O1 ADZHXBNWNZIHIX-XYGAWYNKSA-N 0.000 claims 1
- 238000013016 damping Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract description 22
- 230000004663 cell proliferation Effects 0.000 abstract description 11
- 230000004528 endothelial cell apoptotic process Effects 0.000 abstract description 9
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000010100 anticoagulation Effects 0.000 abstract description 4
- 239000002473 artificial blood Substances 0.000 abstract description 4
- 210000003709 heart valve Anatomy 0.000 abstract description 3
- 230000002792 vascular Effects 0.000 abstract description 3
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 239000012567 medical material Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 12
- 230000003110 anti-inflammatory effect Effects 0.000 description 11
- 239000010935 stainless steel Substances 0.000 description 11
- 229910001220 stainless steel Inorganic materials 0.000 description 11
- 239000003146 anticoagulant agent Substances 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 229940127219 anticoagulant drug Drugs 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000007943 implant Substances 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- 230000004913 activation Effects 0.000 description 6
- 238000001994 activation Methods 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- 230000021164 cell adhesion Effects 0.000 description 5
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000002889 endothelial cell Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 239000004626 polylactic acid Substances 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 230000005660 hydrophilic surface Effects 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000002296 pyrolytic carbon Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002482 anti-endothelial effect Effects 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229910021397 glassy carbon Inorganic materials 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- BDRTVPCFKSUHCJ-UHFFFAOYSA-N molecular hydrogen;potassium Chemical compound [K].[H][H] BDRTVPCFKSUHCJ-UHFFFAOYSA-N 0.000 description 1
- 230000006715 negative regulation of smooth muscle cell proliferation Effects 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- VNWUPXWZDMOTFT-UHFFFAOYSA-N phenol;phthalic acid Chemical class OC1=CC=CC=C1.OC(=O)C1=CC=CC=C1C(O)=O VNWUPXWZDMOTFT-UHFFFAOYSA-N 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种具有超亲水性能的多功能心血管涂层材料及其制备方法。该方法包括以下步骤:(1)对基底材料进行预处理;(2)将经预处理后的基底材料置于缓冲体系中,然后加多酚化合物和的多巴胺,于4~50℃反应2h;再加入高碘酸钠,于4~50℃反应;(3)用去离子水超声清洗步骤(2)所得产物3~5次,氮气干燥,得多功能心血管涂层材料。本发明制备得到的多功能心血管涂层,稳定性好,有优良的亲水性,且具有良好的抗凝血性、抗炎性、抗氧化、避免内皮细胞凋亡和抑制平滑肌细胞增殖的能力,可用于医用材料领域的血管支架、心脏瓣膜、人工血管、血液接触导管等血液接触类材料的制备。The invention discloses a multifunctional cardiovascular coating material with superhydrophilic performance and a preparation method thereof. The method comprises the following steps: (1) pretreating the base material; (2) placing the pretreated base material in a buffer system, then adding polyphenol compounds and dopamine, and reacting at 4-50° C. for 2 hours; Then add sodium periodate and react at 4-50 DEG C; (3) ultrasonically clean the product obtained in step (2) with deionized water for 3-5 times, dry with nitrogen gas, and become a multi-functional cardiovascular coating material. The multifunctional cardiovascular coating prepared by the present invention has good stability, excellent hydrophilicity, good anticoagulation, anti-inflammation, anti-oxidation, ability to avoid endothelial cell apoptosis and inhibit smooth muscle cell proliferation , can be used in the preparation of blood-contact materials such as vascular stents, heart valves, artificial blood vessels, and blood-contact catheters in the field of medical materials.
Description
技术领域technical field
本发明属于医用材料技术领域,具体涉及一种具有超亲水性能的多功能心血管涂层材料及其制备方法,该涂层材料可用于血管支架、心脏瓣膜、人工血管、血液接触导管等血液接触类材料的制备。The invention belongs to the technical field of medical materials, and in particular relates to a multifunctional cardiovascular coating material with superhydrophilic performance and a preparation method thereof. Preparation of contact materials.
背景技术Background technique
具有优良的血液相容性和细胞相容性是生物材料必须满足的条件之一,特别是对于直接与血液接触的心血管材料(例如:血管支架、心脏瓣膜、人工血管、起搏器、人工血管、血液接触导管等),优良的血液相容性是首要的考虑因素。材料与血液接触以后,在极短的时间内发生血浆蛋白(如纤维蛋白原等)的吸附与变性,随后伴随着血小板的粘附、激活与聚集,纤维蛋白网络的形成,最终网罗红血球形成血栓聚集体。最终导致器械植入或使用失败,因此,阻抗纤维蛋白原在材料表面吸附和变性,进而抑制血小板在生物材料表面的吸附、聚集和激活,是改善生物材料血液相容性的方法之一。Having excellent blood compatibility and cell compatibility is one of the conditions that biological materials must meet, especially for cardiovascular materials that are in direct contact with blood (such as: vascular stents, heart valves, artificial blood vessels, pacemakers, artificial Blood vessels, blood contact catheters, etc.), excellent blood compatibility is the primary consideration. After the material comes into contact with blood, the adsorption and denaturation of plasma proteins (such as fibrinogen, etc.) occurs in a very short period of time, followed by the adhesion, activation and aggregation of platelets, the formation of fibrin network, and finally the formation of thrombus by recruiting red blood cells Aggregates. It will eventually lead to the failure of device implantation or use. Therefore, preventing the adsorption and denaturation of fibrinogen on the surface of materials, thereby inhibiting the adsorption, aggregation and activation of platelets on the surface of biomaterials, is one of the methods to improve the hemocompatibility of biomaterials.
同时,材料植入后会造成急性炎症反应,人体中蛋白质在植入体表面的非特异性吸附使得植入体被免疫系统中的巨噬细胞所识别,而巨噬细胞在吞噬未果的情况下通过自我融合形成巨型细胞并分泌细胞因子(24小时内达到峰值),促使成纤维细胞在植入体表面沉积成并最终形成致密的纤维囊并对植入体覆裹,从而对植入材料的服役带来不良影响。植入材料具有良好的血液相容性,同时能有效的抑制炎症细胞的激活和聚集可以有效的防止血液接触器械的感染而带来的植入失效;器械能促进内皮细胞的生长、抑制平滑肌细胞的增殖和迁移的性能,可进一步提高长期血液接触材料的血液相容性且有效避免组织增生带来的器械植入失效。因此,具有较好的抗凝、抗炎、促内皮细胞、抑制平滑肌细胞的生长对心血管植入材料至关重要。At the same time, the implantation of the material will cause an acute inflammatory reaction, and the non-specific adsorption of proteins on the surface of the implant in the human body will make the implant recognized by the macrophages in the immune system, and the macrophages will pass through the body if the phagocytosis fails. Self-fusion to form giant cells and secrete cytokines (peak within 24 hours), prompting fibroblasts to deposit on the surface of the implant and eventually form a dense fibrous capsule and cover the implant, thereby serving the implant material bring adverse effects. The implant material has good blood compatibility, and can effectively inhibit the activation and aggregation of inflammatory cells, which can effectively prevent the implantation failure caused by the infection of the blood contact device; the device can promote the growth of endothelial cells and inhibit the smooth muscle cells Proliferation and migration performance can further improve the blood compatibility of long-term blood contact materials and effectively avoid device implantation failure caused by tissue proliferation. Therefore, it is very important for cardiovascular implant materials to have better anticoagulation, anti-inflammation, promotion of endothelial cells, and inhibition of smooth muscle cell growth.
对于生物医用材料而言,材料表面亲/疏水性是影响蛋白质吸附的首要因素。同时,由于蛋白质是带有两性电荷的聚电解质,若材料表面也带有两亲性离子结构或亲水基团,通过富集水化层或空间排斥也可以削弱材料与蛋白的相互作用,抑制非特异性蛋白的吸附。For biomedical materials, the affinity/hydrophobicity of the material surface is the primary factor affecting protein adsorption. At the same time, since proteins are polyelectrolytes with amphoteric charges, if the surface of the material also has amphiphilic ionic structures or hydrophilic groups, the interaction between the material and the protein can also be weakened by enriching the hydration layer or steric repulsion, inhibiting the Adsorption of non-specific proteins.
而且,目前研究最为广泛的材料表面的亲/疏水性对蛋白吸附和细胞相容性的影响中,比较一致的观点认为亲水性材料比疏水性材料具有更好的生物相容性。因为疏水表面蛋白粘附得较为牢固,不易脱落,且容易导致蛋白质的构象变化;而亲水表面对蛋白的粘附强度较低,有利于蛋白原有自由构象的调整与维持。Moreover, among the effects of hydrophilic/hydrophobic properties on the surface of materials that are most widely studied at present on protein adsorption and cell compatibility, it is generally agreed that hydrophilic materials have better biocompatibility than hydrophobic materials. Because the hydrophobic surface protein adheres more firmly, it is not easy to fall off, and it is easy to cause the conformational change of the protein; while the adhesion strength of the hydrophilic surface to the protein is low, which is conducive to the adjustment and maintenance of the original free conformation of the protein.
传统的制备亲水性表面方法,一般是将亲水性功能基团(如羧酸基、磺酸基、胺基、季胺基)或者是具有亲水性的物质接枝或涂覆在材料表面,而无论是以共价固定还是物理共混涂覆到材料表面,都必须依赖分子的尺寸、构象、活性以及其在材料表面发挥亲水性作用的稳定性及持久性。生物分子一旦在服役过程中失活或大量丢失,便不能有效发挥其生物学功能。因此能在涂层表面直接生成大量稳定的亲水基团且不受接枝过程影响显得尤为重要。The traditional method of preparing a hydrophilic surface is generally to graft or coat a hydrophilic functional group (such as a carboxylic acid group, a sulfonic acid group, an amine group, a quaternary ammonium group) or a hydrophilic substance on the material. The surface, whether it is covalently immobilized or physically blended to coat the surface of the material, must depend on the size, conformation, activity of the molecule, and the stability and persistence of its hydrophilic effect on the surface of the material. Once biomolecules are inactivated or lost in large quantities during service, they cannot effectively perform their biological functions. Therefore, it is particularly important to generate a large number of stable hydrophilic groups directly on the coating surface without being affected by the grafting process.
发明内容Contents of the invention
针对现有技术中的上述不足,本发明提供一种具有超亲水性能的多功能心血管涂层材料及其制备方法,可制备得到一种具有抗凝血、抗炎、抗氧化、避免内皮细胞凋亡和抑制平滑肌细胞增殖作用的多功能心血管涂层。Aiming at the above-mentioned deficiencies in the prior art, the present invention provides a multi-functional cardiovascular coating material with superhydrophilic properties and a preparation method thereof, which can prepare a coating material with anticoagulation, anti-inflammation, anti-oxidation, anti-endothelial A multifunctional cardiovascular coating that inhibits apoptosis and proliferation of smooth muscle cells.
为实现上述目的,本发明解决其技术问题所采用的技术方案是:In order to achieve the above object, the technical solution adopted by the present invention to solve the technical problems is:
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对基底材料进行预处理;(1) Carry out pretreatment to substrate material;
(2)将经预处理后的基底材料置于pH值为3~6的缓冲体系中,然后加入终浓度为0.01mg/mL~10mg/mL的多酚化合物和终浓度为0.01mg/mL~10mg/mL的多巴胺于4~50℃反应2h;再加入终浓度为0.01mg/mL-10mg/mL的高碘酸钠,于4~50℃反应0.1~48h;(2) Place the pretreated base material in a buffer system with a pH value of 3 to 6, then add polyphenol compounds with a final concentration of 0.01 mg/mL to 10 mg/mL and a final concentration of 0.01 mg/mL to 10mg/mL dopamine was reacted at 4-50°C for 2h; then sodium periodate with a final concentration of 0.01mg/mL-10mg/mL was added, and reacted at 4-50°C for 0.1-48h;
(3)用去离子水超声清洗步骤(2)所得产物3~5次,每次2~5min,氮气干燥,得具有超亲水性能的多功能心血管涂层材料。(3) Ultrasonic cleaning of the product obtained in step (2) with deionized water for 3 to 5 times, each time for 2 to 5 minutes, and drying with nitrogen gas to obtain a multifunctional cardiovascular coating material with superhydrophilic properties.
进一步地,步骤(1)中基底材料为金属材料、陶瓷材料、高分子材料或复合生物材料。Further, the base material in step (1) is metal material, ceramic material, polymer material or composite biological material.
其中,金属材料为不锈钢、钴基合金、钛及其合金、镁及其合金或纯铁;Among them, the metal materials are stainless steel, cobalt-based alloys, titanium and its alloys, magnesium and its alloys, or pure iron;
陶瓷材料为医用无机材料与薄膜-TiO2、各向同性热解碳(Low TemperatureIsotropic Pyrolytic Carbon,LTIC)、玻璃碳、金刚石、类金刚石或氧化铝(Al2O3);Ceramic materials are medical inorganic materials and thin films-TiO 2 , Low Temperature Isotropic Pyrolytic Carbon (LTIC), glassy carbon, diamond, diamond-like carbon or aluminum oxide (Al 2 O 3 );
高分子材料为聚乙烯、聚氯乙烯、聚四氟乙烯、聚丙烯、聚甲基丙烯酸甲酯、医用聚砜、医用聚硅氧烷、聚醚砜膜、聚乳酸、聚羟基乙酸、乙交酯-丙交酯共聚物PLGA、聚氨酯、医用胶原或天然橡胶;Polymer materials are polyethylene, polyvinyl chloride, polytetrafluoroethylene, polypropylene, polymethyl methacrylate, medical polysulfone, medical polysiloxane, polyethersulfone membrane, polylactic acid, polyglycolic acid, glycolic acid Ester-lactide copolymer PLGA, polyurethane, medical collagen or natural rubber;
复合生物材料为不锈钢纤维、钛纤维增强生物玻璃、聚乳酸、乙醇酸纤维或羟基磷灰石增强聚乳酸。The composite biomaterial is stainless steel fiber, titanium fiber reinforced bioglass, polylactic acid, glycolic acid fiber or hydroxyapatite reinforced polylactic acid.
进一步地,步骤(2)中多酚化合物的终浓度为2mg/mL。Further, the final concentration of the polyphenol compound in step (2) is 2 mg/mL.
进一步地,多酚化合物为单宁酸、没食子酸、丹酚酸B、表没食子儿茶素没食子酸酯、表儿茶素没食子酸酯、表儿茶素、表没食子儿茶素、邻苯二酚、邻苯三酚、黄酮类、花色素苷、鞣花酸或原花色素A2。Further, the polyphenolic compound is tannic acid, gallic acid, salvianolic acid B, epigallocatechin gallate, epicatechin gallate, epicatechin, epigallocatechin, phthalate Phenols, pyrogallol, flavonoids, anthocyanins, ellagic acid or proanthocyanidins A2.
进一步地,步骤(2)中多巴胺的终浓度为4mg/mL。Further, the final concentration of dopamine in step (2) is 4 mg/mL.
进一步地,步骤(2)中高碘酸钠的终浓度为4mg/ml。Further, the final concentration of sodium periodate in step (2) is 4mg/ml.
进一步地,步骤(2)中缓冲体系为乙酸-乙酸盐缓冲液、2-(N-吗啡啉)乙磺酸缓冲液、甘氨酸-盐酸缓冲液、邻苯二甲酸-盐酸缓冲液、邻苯二甲酸氢钾-氢氧化钠缓冲液、磷酸氢二钠-柠檬酸缓冲液、柠檬酸-氢氧化钠-盐酸缓冲液或柠檬酸-柠檬酸钠缓冲液。Further, the buffer system in step (2) is acetic acid-acetate buffer, 2-(N-morpholine) ethanesulfonic acid buffer, glycine-hydrochloric acid buffer, phthalic acid-hydrochloric acid buffer, o-phthalic acid Potassium hydrogen diformate-sodium hydroxide buffer, disodium hydrogen phosphate-citric acid buffer, citric acid-sodium hydroxide-hydrochloric acid buffer or citric acid-sodium citrate buffer.
上述方法制备得到的具有超亲水性能的多功能心血管涂层材料。The multifunctional cardiovascular coating material with superhydrophilic properties prepared by the above method.
本发明的有益效果为:The beneficial effects of the present invention are:
1、多酚化合物由于其具有邻酚羟基官能团,与基底材料存在相互作用力,在粘附化学领域被广泛研究。此外,多酚可以与含有氨基或巯基的化合物发生化学交联,并且能在多种金属、无机材料和聚合物表面沉积形成含邻酚基团的聚合薄膜。同时,多酚化合物具有良好的抗氧化能力、抑制细菌的生长、抑制巨噬细胞的激活和聚集、强化血管壁、促进内皮细胞的生长、抑制平滑肌细胞的增殖和迁移的性能。因此近年来,多酚化合物在生物医用材料表面改性领域也受到了广泛的研究和关注。1. Polyphenolic compounds have been widely studied in the field of adhesion chemistry because of their ortho-phenolic hydroxyl functional groups and the interaction with substrate materials. In addition, polyphenols can be chemically cross-linked with compounds containing amino or mercapto groups, and can be deposited on the surface of various metals, inorganic materials and polymers to form polymeric films containing ortho-phenolic groups. At the same time, polyphenol compounds have good antioxidant capacity, inhibit the growth of bacteria, inhibit the activation and aggregation of macrophages, strengthen the blood vessel wall, promote the growth of endothelial cells, and inhibit the proliferation and migration of smooth muscle cells. Therefore, in recent years, polyphenolic compounds have also received extensive research and attention in the field of surface modification of biomedical materials.
2、多酚化合物、多巴胺和高碘酸钠三者以共价、氢键、疏水作用力及超分子作用力等多种模式相互作用,与材料表面发生物理/化学沉积,形成多酚涂层;并且,多酚化合物在与氧化剂反应过程中,被氧化剂的电子攻击,使得邻二醌结构转化为羧基结构,使得涂层有大量的羧基生成,形成亲水表面,在涂层表面生成多种亲水功能基团(如-COOH、-NH2、酚-OH等),从而使得涂层具有良好的亲水性,得益于优良的亲水性,使得涂层表面具有很好的抗污性,可以有效阻抗非特异性蛋白(如:纤维蛋白原、白蛋白等)的粘附和变性,并进一步阻止血小板的粘附和激活。2. Polyphenolic compounds, dopamine and sodium periodate interact in multiple modes such as covalent, hydrogen bond, hydrophobic force and supramolecular force, and physically/chemically deposit with the surface of the material to form a polyphenol coating and, during the reaction of the polyphenol compound with the oxidizing agent, it is attacked by the electrons of the oxidizing agent, so that the o-diquinone structure is converted into a carboxyl structure, so that the coating has a large amount of carboxyl groups to form a hydrophilic surface, and a variety of Hydrophilic functional groups (such as -COOH, -NH 2 , phenol-OH, etc.), so that the coating has good hydrophilicity, thanks to the excellent hydrophilicity, the surface of the coating has good anti-fouling properties It can effectively resist the adhesion and denaturation of non-specific proteins (such as fibrinogen, albumin, etc.), and further prevent the adhesion and activation of platelets.
3、另外,涂层中未反应的多酚可以发挥其良好的生物学功能,包括抗氧化性、抗炎症反应、抗菌性、对内皮细胞友好且抑制平滑肌细胞增殖等等。此外大量的亲水基团可以作为后续生物分子接枝改性的平台,从而可有效地提高材料表面的生物相容性。目前尚未报道利用多酚与氧化剂作用在生物材料表面制备同时具有抗炎、抗凝血、避免内细胞凋亡、抑制平滑肌细胞增殖且富含活性官能团涂层的报道。3. In addition, the unreacted polyphenols in the coating can exert its good biological functions, including antioxidant, anti-inflammatory, antibacterial, friendly to endothelial cells and inhibiting smooth muscle cell proliferation, etc. In addition, a large number of hydrophilic groups can be used as a platform for subsequent biomolecular graft modification, which can effectively improve the biocompatibility of the material surface. At present, there is no report on the use of polyphenols and oxidants to prepare coatings on the surface of biomaterials that are anti-inflammatory, anti-coagulant, avoid inner cell apoptosis, inhibit smooth muscle cell proliferation, and are rich in active functional groups.
4、多酚类化合物的分子结构中含有大量的邻位酚羟基,在涂层中,这些邻位酚羟基可与金属形成稳定的螯合作用,多酚交联涂层能在金属表面形成较稳定的结合,该交联聚合涂层还能通过分子间疏水相互作用和氢键作用与基底材料形成较稳定的结合,这样的涂层与各类生物材料基底具有优良的结合力,尤其适用于血管支架、心脏瓣膜、人工血管、血液接触导管等血液接触类材料的制备。4. The molecular structure of polyphenolic compounds contains a large number of ortho phenolic hydroxyl groups. In the coating, these ortho phenolic hydroxyl groups can form a stable chelation with metals, and the polyphenol crosslinked coating can form a relatively Stable combination, the cross-linked polymeric coating can also form a relatively stable combination with the substrate material through intermolecular hydrophobic interactions and hydrogen bonds, such a coating has excellent binding force with various biological material substrates, especially suitable for Preparation of blood-contact materials such as vascular stents, heart valves, artificial blood vessels, and blood-contact catheters.
5、本发明所需制备的涂层通常低于200nm,所得涂层均匀,制备涂层所需原料投入很少,原料投入量易于调控,该涂层可以在多种材料表面进行修饰而不影响本体材料的性能。与传统的抗凝涂层技术相比,操作简单,成本较低,普适性广。5. The coating required by the present invention is usually lower than 200nm, and the resulting coating is uniform. The raw material input required for preparing the coating is small, and the amount of raw material input is easy to control. The coating can be modified on the surface of various materials without affecting properties of the bulk material. Compared with the traditional anti-coagulation coating technology, the operation is simple, the cost is low, and the universality is wide.
附图说明Description of drawings
图1是血小板粘附的扫描电镜(SEM)图;其中,A为传统多酚沉积薄膜血小板粘附的扫描电镜(SEM)图;B为实施例3所得多功能心血管涂层血小板粘附的扫描电镜(SEM)图;Fig. 1 is the scanning electron microscope (SEM) figure of platelet adhesion; Wherein, A is the scanning electron microscope (SEM) figure of traditional polyphenol deposition film platelet adhesion; Scanning electron microscope (SEM) picture;
图2为平滑肌细胞粘附的激光共聚焦(CLSM)图;其中,A为传统多酚沉积薄膜平滑肌细胞粘附的激光共聚焦(CLSM)图,B为实施例3所得多功能心血管涂层平滑肌细胞粘附的激光共聚焦(CLSM)图。Fig. 2 is the laser confocal (CLSM) figure of smooth muscle cell adhesion; Wherein, A is the laser confocal (CLSM) figure of smooth muscle cell adhesion of traditional polyphenol deposition film, B is the multifunctional cardiovascular coating obtained in embodiment 3 Confocal laser (CLSM) images of smooth muscle cell adhesion.
具体实施方式Detailed ways
下面对本发明的具体实施方式进行描述,以便于本技术领域的技术人员理解本发明,但应该清楚,本发明不限于具体实施方式的范围,对本技术领域的普通技术人员来讲,只要各种变化在所附的权利要求限定和确定的本发明的精神和范围内,这些变化是显而易见的,一切利用本发明构思的发明创造均在保护之列。The specific embodiments of the present invention are described below so that those skilled in the art can understand the present invention, but it should be clear that the present invention is not limited to the scope of the specific embodiments. For those of ordinary skill in the art, as long as various changes Within the spirit and scope of the present invention defined and determined by the appended claims, these changes are obvious, and all inventions and creations using the concept of the present invention are included in the protection list.
实施例1Example 1
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对需要改性修饰的医用不锈钢进行抛光,然后清洗干燥;(1) Polish the medical stainless steel that needs to be modified, and then clean and dry;
(2)将处理后的不锈钢置于pH值为4的乙酸-乙酸盐缓冲液中,然后依次加入在缓冲体系中终浓度为0.01mg/mL的没食子酸、终浓度为0.01mg/mL的多巴胺于40℃反应2h;然后再加入终浓度0.01mg/ml的高碘酸钠溶液,于40℃,反应30h;(2) Place the treated stainless steel in an acetic acid-acetate buffer solution with a pH value of 4, then add gallic acid with a final concentration of 0.01 mg/mL and gallic acid with a final concentration of 0.01 mg/mL in the buffer system successively. Dopamine was reacted at 40°C for 2h; then sodium periodate solution with a final concentration of 0.01mg/ml was added, and reacted at 40°C for 30h;
(3)用去离子水超声清洗步骤(2)所得产物3次,每次5min,然后在氮气条件下干燥,即可制备得到具有超亲水性能,且兼具抗凝血、抗炎、抗氧化、避免内皮细胞凋亡、抑制平滑肌细胞增殖多功能心血管涂层。(3) Use deionized water to ultrasonically clean the product obtained in step (2) for 3 times, each time for 5 minutes, and then dry it under nitrogen to prepare a super-hydrophilic, anti-coagulant, anti-inflammatory and anti-inflammatory product. Oxidation, avoidance of endothelial cell apoptosis, inhibition of smooth muscle cell proliferation in a multifunctional cardiovascular coating.
实施例2Example 2
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对需要改性修饰的镍钛合金进行抛光,然后清洗干燥;(1) Polish the nickel-titanium alloy that needs to be modified, and then clean and dry;
(2)将处理后的不锈钢置于pH值为3.5的邻苯二甲酸-盐酸缓冲液中,然后加入在缓冲体系中终浓度为1mg/mL的表没食子儿茶素没食子酸酯(EGCG)、终浓度为2mg/mL的多巴胺于30℃反应2h;然后再加入终浓度为2mg/mL的高碘酸钠溶液,于30℃,反应10h;(2) Place the treated stainless steel in a phthalic acid-hydrochloric acid buffer solution with a pH value of 3.5, and then add epigallocatechin gallate (EGCG) with a final concentration of 1 mg/mL in the buffer system, Dopamine with a final concentration of 2mg/mL was reacted at 30°C for 2h; then sodium periodate solution with a final concentration of 2mg/mL was added and reacted at 30°C for 10h;
(3)用去离子水清洗步骤(2)所得产物3次,每次5min,然后在氮气条件下干燥,即可制备得到具有超亲水性能,且兼具抗凝血、抗炎、抗氧化、避免内皮细胞凋亡、抑制平滑肌细胞增殖多功能心血管涂层。(3) Wash the product obtained in step (2) with deionized water for 3 times, each time for 5 minutes, and then dry it under nitrogen to prepare a super-hydrophilic, anti-coagulant, anti-inflammatory, and anti-oxidative product , Avoid endothelial cell apoptosis, inhibit smooth muscle cell proliferation multifunctional cardiovascular coating.
实施例3Example 3
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对需要改性修饰的聚四氟乙烯进行清洗干燥;(1) cleaning and drying the polytetrafluoroethylene that needs to be modified;
(2)将处理后的不锈钢置于pH值为6的2-(N-吗啡啉)乙磺酸缓冲液中,然后依次加入在缓冲体系中终浓度为2mg/mL的表儿茶素没食子酸酯(ECG)、终浓度为4mg/mL的多巴胺于15℃反应2h;然后再加入终浓度为4mg/mL的高碘酸钠溶液,于15℃,反应24h;(2) Place the treated stainless steel in 2-(N-morpholine) ethanesulfonic acid buffer solution with a pH value of 6, and then add epicatechin gallic acid with a final concentration of 2 mg/mL in the buffer system Ester (ECG) and dopamine with a final concentration of 4mg/mL were reacted at 15°C for 2h; then sodium periodate solution with a final concentration of 4mg/mL was added and reacted at 15°C for 24h;
(3)用去离子水清洗步骤(2)所得产物3次,每次5min,然后在氮气条件下干燥,即可制备得到具有超亲水性能,且兼具抗凝血、抗炎、抗氧化、避免内皮细胞凋亡、抑制平滑肌细胞增殖多功能心血管涂层。(3) Wash the product obtained in step (2) with deionized water for 3 times, each time for 5 minutes, and then dry it under nitrogen to prepare a super-hydrophilic, anti-coagulant, anti-inflammatory, and anti-oxidative product , Avoid endothelial cell apoptosis, inhibit smooth muscle cell proliferation multifunctional cardiovascular coating.
实施例4Example 4
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对需要改性修饰的聚氨酯进行清洗干燥;(1) cleaning and drying the polyurethane that needs to be modified;
(2)将处理后的不锈钢置于pH值为6的柠檬酸-柠檬酸钠缓冲液中,然后依次加入在缓冲体系中终浓度为2mg/mL的没食子酸、终浓度为5mg/mL的多巴胺于20℃反应2h;然后再加入终浓度为2mg/mL的高碘酸钠溶液,于20℃,反应18h;(2) Place the treated stainless steel in a citric acid-sodium citrate buffer solution with a pH value of 6, then add gallic acid with a final concentration of 2 mg/mL and dopamine with a final concentration of 5 mg/mL in the buffer system React at 20°C for 2h; then add sodium periodate solution with a final concentration of 2mg/mL, and react at 20°C for 18h;
(3)用去离子水清洗步骤(2)所得产物3次,每次5min,然后在氮气条件下干燥,即可制备得到具有超亲水性能,且兼具抗凝血、抗炎、抗氧化、避免内皮细胞凋亡、抑制平滑肌细胞增殖多功能心血管涂层。(3) Wash the product obtained in step (2) with deionized water for 3 times, each time for 5 minutes, and then dry it under nitrogen to prepare a super-hydrophilic, anti-coagulant, anti-inflammatory, and anti-oxidative product , Avoid endothelial cell apoptosis, inhibit smooth muscle cell proliferation multifunctional cardiovascular coating.
实施例5Example 5
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对需要改性修饰的各向同性热解碳LTIC材料进行抛光,然后清洗干燥;(1) Polish the isotropic pyrolytic carbon LTIC material that needs to be modified, then clean and dry;
(2)将处理后的不锈钢置于pH值为4.5的邻苯二甲酸氢钾-氢氧化钠缓冲液中,然后依次加入在缓冲体系中终浓度为5mg/mL的具有表儿茶素(EC)的化合物、终浓度为7mg/mL的多巴胺于25℃反应2h;然后再加入终浓度7mg/ml的高碘酸钠溶液,于25℃,反应6h;(2) Place the treated stainless steel in a potassium hydrogen phthalate-sodium hydroxide buffer solution with a pH value of 4.5, and then sequentially add epicatechin (EC) with a final concentration of 5 mg/mL in the buffer system. ) compound and dopamine with a final concentration of 7mg/mL were reacted at 25°C for 2h; then sodium periodate solution with a final concentration of 7mg/ml was added and reacted at 25°C for 6h;
(3)用去离子水清洗步骤(2)所得产物3次,每次5min,然后在氮气条件下干燥,即可制备得到具有超亲水性能,且兼具抗凝血、抗炎、抗氧化、避免内皮细胞凋亡、抑制平滑肌细胞增殖多功能心血管涂层。(3) Wash the product obtained in step (2) with deionized water for 3 times, each time for 5 minutes, and then dry it under nitrogen to prepare a super-hydrophilic, anti-coagulant, anti-inflammatory, and anti-oxidative product , Avoid endothelial cell apoptosis, inhibit smooth muscle cell proliferation multifunctional cardiovascular coating.
实施例6Example 6
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对需要改性修饰的医用胶原进行清洗干燥;(1) Clean and dry the medical collagen that needs to be modified;
(2)将处理后的不锈钢置于pH值为4的甘氨酸-盐酸缓冲液中,然后依次加入在缓冲体系中终浓度为0.1mg/mL的表没食子儿茶素EGC、终浓度为0.5mg/mL的多巴胺于30℃反应2h;然后再加入终浓度为0.5mg/mL的高碘酸钠溶液,于30℃,反应12h;(2) Place the treated stainless steel in a glycine-hydrochloric acid buffer solution with a pH value of 4, then add epigallocatechin EGC with a final concentration of 0.1 mg/mL in the buffer system, and a final concentration of 0.5 mg/mL. mL of dopamine was reacted at 30°C for 2h; then sodium periodate solution with a final concentration of 0.5mg/mL was added and reacted at 30°C for 12h;
(3)用去离子水清洗步骤(2)所得产物3次,每次5min,然后在氮气条件下干燥,即可制备得到具有超亲水性能,且兼具抗凝血、抗炎、抗氧化、避免内皮细胞凋亡、抑制平滑肌细胞增殖多功能心血管涂层。(3) Wash the product obtained in step (2) with deionized water for 3 times, each time for 5 minutes, and then dry it under nitrogen to prepare a super-hydrophilic, anti-coagulant, anti-inflammatory, and anti-oxidative product , Avoid endothelial cell apoptosis, inhibit smooth muscle cell proliferation multifunctional cardiovascular coating.
实施例7Example 7
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对需要改性修饰的天然橡胶进行清洗干燥;(1) cleaning and drying the natural rubber that needs to be modified;
(2)将处理后的不锈钢置于pH值为5.5的磷酸氢二钠-柠檬酸缓冲液中,然后依次加入在缓冲体系中终浓度为7mg/mL的邻苯三酚、终浓度为10mg/mL的多巴胺于40℃反应2h;然后再加入终浓度为10mg/mL的高碘酸钠溶液,于40℃,反应1h;(2) Place the treated stainless steel in a disodium hydrogen phosphate-citric acid buffer solution with a pH value of 5.5, then add successively pyrogallol with a final concentration of 7 mg/mL in the buffer system, and a final concentration of 10 mg/mL. mL of dopamine was reacted at 40°C for 2h; then sodium periodate solution with a final concentration of 10mg/mL was added and reacted at 40°C for 1h;
(3)用去离子水清洗步骤(2)所得产物3次,每次5min,然后在氮气条件下干燥,即可制备得到具有超亲水性能,且兼具抗凝血、抗炎、抗氧化、避免内皮细胞凋亡、抑制平滑肌细胞增殖多功能心血管涂层。(3) Wash the product obtained in step (2) with deionized water for 3 times, each time for 5 minutes, and then dry it under nitrogen to prepare a super-hydrophilic, anti-coagulant, anti-inflammatory, and anti-oxidative product , Avoid endothelial cell apoptosis, inhibit smooth muscle cell proliferation multifunctional cardiovascular coating.
实施例8Example 8
一种具有超亲水性能的多功能心血管涂层材料的制备方法,包括以下步骤:A preparation method of a multifunctional cardiovascular coating material with superhydrophilic properties, comprising the following steps:
(1)对需要改性修饰的羟基磷灰石增强聚乳酸进行清洗干燥;(1) cleaning and drying the hydroxyapatite-reinforced polylactic acid that needs to be modified;
(2)将处理后的不锈钢置于pH值为6的乙酸-乙酸盐缓冲液中,然后依次加入在缓冲体系中终浓度为3mg/mL的没食子酸、终浓度为1mg/mL的多巴胺于45℃反应2h;然后再加入终浓度为1mg/mL的高碘酸钠溶液,于45℃,反应4h;(2) Place the treated stainless steel in the acetic acid-acetate buffer solution with a pH value of 6, then add gallic acid with a final concentration of 3 mg/mL and dopamine with a final concentration of 1 mg/mL in the buffer system successively. React at 45°C for 2h; then add sodium periodate solution with a final concentration of 1mg/mL, and react at 45°C for 4h;
(3)用去离子水清洗步骤(2)所得产物3次,每次5min,然后在氮气条件下干燥,即可制备得到具有超亲水性能,且兼具抗凝血、抗炎、抗氧化、避免内皮细胞凋亡、抑制平滑肌细胞增殖多功能心血管涂层。(3) Wash the product obtained in step (2) with deionized water for 3 times, each time for 5 minutes, and then dry it under nitrogen to prepare a super-hydrophilic, anti-coagulant, anti-inflammatory, and anti-oxidative product , Avoid endothelial cell apoptosis, inhibit smooth muscle cell proliferation multifunctional cardiovascular coating.
检测detection
分别检测传统的多酚涂层和本发明实施例3制备得到的多功能心血管涂层的血小板和平滑肌细胞的粘附性,其结果分别见图1和图2。The adhesion of platelets and smooth muscle cells of the traditional polyphenol coating and the multifunctional cardiovascular coating prepared in Example 3 of the present invention were tested respectively, and the results are shown in Fig. 1 and Fig. 2 respectively.
如图1所示,其中,A传统多酚沉积薄膜血小板粘附的扫描电镜(SEM)图,B为实施例3所得多功能心血管涂层血小板粘附的扫描电镜(SEM)图;从检测结果图中可以看出,相比传统的多酚涂层,本发明实施例3制备得到的多功能心血管涂层表面的血小板粘附数量、聚集和激活程度得到显著抑制,表明本发明制备得到的多功能心血管涂层具有优异的抗血小板粘附性能。As shown in Figure 1, wherein, the scanning electron microscope (SEM) figure of A traditional polyphenol deposition film platelet adhesion, B is the scanning electron microscope (SEM) figure of embodiment 3 gained multifunctional cardiovascular coating platelet adhesion; From detection As can be seen from the result figure, compared with the traditional polyphenol coating, the platelet adhesion quantity, aggregation and activation degree on the surface of the multifunctional cardiovascular coating prepared in Example 3 of the present invention are significantly inhibited, indicating that the present invention prepares The multifunctional cardiovascular coating has excellent anti-platelet adhesion properties.
如图2所示,其中,A为传统多酚沉积薄膜平滑肌细胞粘附的激光共聚焦(CLSM)图,B为实施例3所得多功能心血管涂层平滑肌细胞粘附的激光共聚焦(CLSM)图;从检测结果图中可以看出,相比传统的多酚涂层,本发明实施例3制备得到的多功能心血管涂层表面的平滑肌细胞的粘附数量和生长形态得到显著抑制,表明本发明制备得到的多功能心血管涂层具有优异的抑制平滑肌细胞增生性能。As shown in Figure 2, wherein, A is the laser confocal (CLSM) figure of traditional polyphenol deposition film smooth muscle cell adhesion, and B is the laser confocal (CLSM) of embodiment 3 multifunctional cardiovascular coating smooth muscle cell adhesion ) figure; as can be seen from the detection result figure, compared with the traditional polyphenol coating, the adhesion quantity and growth form of the smooth muscle cells on the surface of the multifunctional cardiovascular coating prepared in Example 3 of the present invention are significantly inhibited, It shows that the multifunctional cardiovascular coating prepared by the present invention has excellent performance of inhibiting the proliferation of smooth muscle cells.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810731279.9A CN108785748B (en) | 2018-07-05 | 2018-07-05 | Multifunctional cardiovascular coating material with super-hydrophilic performance and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810731279.9A CN108785748B (en) | 2018-07-05 | 2018-07-05 | Multifunctional cardiovascular coating material with super-hydrophilic performance and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108785748A true CN108785748A (en) | 2018-11-13 |
CN108785748B CN108785748B (en) | 2020-03-10 |
Family
ID=64075052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810731279.9A Active CN108785748B (en) | 2018-07-05 | 2018-07-05 | Multifunctional cardiovascular coating material with super-hydrophilic performance and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108785748B (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110152064A (en) * | 2019-06-04 | 2019-08-23 | 四川大学 | A kind of heart valve modified by hydrophilic composite network laminate and its preparation method |
CN110755697A (en) * | 2019-11-18 | 2020-02-07 | 湖南省人民医院 | A method for preparing high-efficiency anticoagulant biomaterials by using aqueous solution and corresponding materials |
CN111671983A (en) * | 2020-06-12 | 2020-09-18 | 深圳清华大学研究院 | Biomedical material and preparation method thereof |
CN111840661A (en) * | 2020-07-30 | 2020-10-30 | 齐鲁工业大学 | A kind of high potential superhydrophilic polypeptide monolayer film and its preparation method and application |
CN112741930A (en) * | 2020-12-22 | 2021-05-04 | 四川大学 | Enzyme modified anticoagulation valve and preparation method thereof |
CN112791230A (en) * | 2021-01-28 | 2021-05-14 | 四川大学 | Gene-eluting coating material with oxidative stress damage repair and preparation method thereof |
CN112891619A (en) * | 2021-01-28 | 2021-06-04 | 四川大学 | Gene elution coating material with function of selectively inhibiting smooth muscle cell phenotype transformation and preparation method thereof |
CN113181423A (en) * | 2021-05-26 | 2021-07-30 | 四川大学 | Titanium material with nano hydroxyapatite growing on surface in situ and preparation method and application thereof |
CN113769177A (en) * | 2021-08-26 | 2021-12-10 | 四川大学 | Degradable occluder coating and preparation method thereof |
CN114099785A (en) * | 2021-11-22 | 2022-03-01 | 四川大学 | A kind of cardiovascular implant intervention material/device biofilm coating and preparation method thereof |
CN114452449A (en) * | 2022-02-10 | 2022-05-10 | 自贡市第一人民医院 | Stent coating capable of inhibiting vascular endothelial cell inflammation and preparation method thereof |
CN114632192A (en) * | 2022-03-23 | 2022-06-17 | 东莞市人民医院 | Strontium-phenol chelate self-assembled coating material, preparation method and application thereof |
CN115137879A (en) * | 2022-03-16 | 2022-10-04 | 四川大学 | Blood contact material for resisting coagulation and promoting vascular repair and preparation method thereof |
CN115197899A (en) * | 2022-07-20 | 2022-10-18 | 淮阴工学院 | A preparation method of a coating layer that can regulate the differentiation trend of endothelial progenitor cells |
CN115192774A (en) * | 2022-07-20 | 2022-10-18 | 四川大学 | Wear-resistant multifunctional cell membrane coating and preparation method thereof |
CN115975238A (en) * | 2023-02-10 | 2023-04-18 | 中南大学湘雅医院 | Ethylenediaminetetraacetic acid modified membrane artificial organ material and preparation method thereof |
CN116003675A (en) * | 2022-12-09 | 2023-04-25 | 万华化学集团股份有限公司 | Acrylic emulsion for blood compatibility coating and preparation method thereof |
CN116285684A (en) * | 2023-05-15 | 2023-06-23 | 四川绚度眼视光科技有限公司 | Multifunctional super-hydrophilic coating and preparation method and application thereof |
CN117018303A (en) * | 2023-08-17 | 2023-11-10 | 江门市泰乐医疗科技有限公司 | Surface hydrophilic coating of medical material and preparation method thereof |
CN118557814A (en) * | 2024-08-01 | 2024-08-30 | 四川大学 | Cell membrane coating with pit-shaped topological structure, and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002060505A2 (en) * | 2001-01-31 | 2002-08-08 | Medtronic, Inc. | Method for coating medical device surfaces |
CN106317442A (en) * | 2016-08-17 | 2017-01-11 | 大连理工大学 | Dopamine and dopamine derivative polymerization and high-molecular material surface modification technology |
CN107237134A (en) * | 2017-07-14 | 2017-10-10 | 天津工业大学 | A kind of supper-fast hydrophilic preparation method of modified polypropene non-woven fabrics of polyphenol |
-
2018
- 2018-07-05 CN CN201810731279.9A patent/CN108785748B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002060505A2 (en) * | 2001-01-31 | 2002-08-08 | Medtronic, Inc. | Method for coating medical device surfaces |
CN106317442A (en) * | 2016-08-17 | 2017-01-11 | 大连理工大学 | Dopamine and dopamine derivative polymerization and high-molecular material surface modification technology |
CN107237134A (en) * | 2017-07-14 | 2017-10-10 | 天津工业大学 | A kind of supper-fast hydrophilic preparation method of modified polypropene non-woven fabrics of polyphenol |
Non-Patent Citations (1)
Title |
---|
罗日方: "基于多酚的心血管材料表面多功能涂层研究", 《中国博士学位论文全文数据库 医药卫生科技辑》 * |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110152064A (en) * | 2019-06-04 | 2019-08-23 | 四川大学 | A kind of heart valve modified by hydrophilic composite network laminate and its preparation method |
CN110755697A (en) * | 2019-11-18 | 2020-02-07 | 湖南省人民医院 | A method for preparing high-efficiency anticoagulant biomaterials by using aqueous solution and corresponding materials |
CN110755697B (en) * | 2019-11-18 | 2021-01-15 | 湖南省人民医院 | Method for preparing efficient anticoagulant biological material by using aqueous solution and corresponding material |
CN111671983A (en) * | 2020-06-12 | 2020-09-18 | 深圳清华大学研究院 | Biomedical material and preparation method thereof |
CN111840661A (en) * | 2020-07-30 | 2020-10-30 | 齐鲁工业大学 | A kind of high potential superhydrophilic polypeptide monolayer film and its preparation method and application |
CN111840661B (en) * | 2020-07-30 | 2021-08-10 | 齐鲁工业大学 | High-potential super-hydrophilic polypeptide single-layer film and preparation method and application thereof |
CN112741930A (en) * | 2020-12-22 | 2021-05-04 | 四川大学 | Enzyme modified anticoagulation valve and preparation method thereof |
WO2022135453A1 (en) * | 2020-12-22 | 2022-06-30 | 吉林启明皓月生物科技有限公司 | Enzyme-modified anticoagulant valve and manufacturing method therefor |
CN112791230A (en) * | 2021-01-28 | 2021-05-14 | 四川大学 | Gene-eluting coating material with oxidative stress damage repair and preparation method thereof |
CN112891619A (en) * | 2021-01-28 | 2021-06-04 | 四川大学 | Gene elution coating material with function of selectively inhibiting smooth muscle cell phenotype transformation and preparation method thereof |
CN112891619B (en) * | 2021-01-28 | 2021-10-26 | 四川大学 | Gene elution coating material with function of selectively inhibiting smooth muscle cell phenotype transformation and preparation method thereof |
CN113181423A (en) * | 2021-05-26 | 2021-07-30 | 四川大学 | Titanium material with nano hydroxyapatite growing on surface in situ and preparation method and application thereof |
CN113769177A (en) * | 2021-08-26 | 2021-12-10 | 四川大学 | Degradable occluder coating and preparation method thereof |
CN114099785A (en) * | 2021-11-22 | 2022-03-01 | 四川大学 | A kind of cardiovascular implant intervention material/device biofilm coating and preparation method thereof |
CN114452449A (en) * | 2022-02-10 | 2022-05-10 | 自贡市第一人民医院 | Stent coating capable of inhibiting vascular endothelial cell inflammation and preparation method thereof |
CN115137879B (en) * | 2022-03-16 | 2023-01-10 | 四川大学 | A blood contact material for anticoagulation and promoting blood vessel repair and preparation method thereof |
CN115137879A (en) * | 2022-03-16 | 2022-10-04 | 四川大学 | Blood contact material for resisting coagulation and promoting vascular repair and preparation method thereof |
CN114632192A (en) * | 2022-03-23 | 2022-06-17 | 东莞市人民医院 | Strontium-phenol chelate self-assembled coating material, preparation method and application thereof |
CN114632192B (en) * | 2022-03-23 | 2023-03-17 | 东莞市人民医院 | Strontium-phenol chelate self-assembled coating material, its preparation method and application |
CN115192774A (en) * | 2022-07-20 | 2022-10-18 | 四川大学 | Wear-resistant multifunctional cell membrane coating and preparation method thereof |
CN115197899A (en) * | 2022-07-20 | 2022-10-18 | 淮阴工学院 | A preparation method of a coating layer that can regulate the differentiation trend of endothelial progenitor cells |
CN115197899B (en) * | 2022-07-20 | 2023-06-30 | 淮阴工学院 | A method for preparing a coating layer that can regulate the differentiation trend of endothelial progenitor cells |
CN116003675A (en) * | 2022-12-09 | 2023-04-25 | 万华化学集团股份有限公司 | Acrylic emulsion for blood compatibility coating and preparation method thereof |
CN116003675B (en) * | 2022-12-09 | 2024-05-03 | 万华化学集团股份有限公司 | Acrylic emulsion for blood compatibility coating and preparation method thereof |
CN115975238A (en) * | 2023-02-10 | 2023-04-18 | 中南大学湘雅医院 | Ethylenediaminetetraacetic acid modified membrane artificial organ material and preparation method thereof |
CN116285684A (en) * | 2023-05-15 | 2023-06-23 | 四川绚度眼视光科技有限公司 | Multifunctional super-hydrophilic coating and preparation method and application thereof |
CN116285684B (en) * | 2023-05-15 | 2023-08-08 | 四川绚度眼视光科技有限公司 | Multifunctional super-hydrophilic coating and preparation method and application thereof |
CN117018303A (en) * | 2023-08-17 | 2023-11-10 | 江门市泰乐医疗科技有限公司 | Surface hydrophilic coating of medical material and preparation method thereof |
CN118557814A (en) * | 2024-08-01 | 2024-08-30 | 四川大学 | Cell membrane coating with pit-shaped topological structure, and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108785748B (en) | 2020-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108785748B (en) | Multifunctional cardiovascular coating material with super-hydrophilic performance and preparation method thereof | |
CN108815587B (en) | A kind of hydrogel coating with long-term antibacterial function and preparation method thereof | |
Li et al. | The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization | |
CN108815586A (en) | A kind of biological anti-pollution layer and preparation method thereof with long-acting super-hydrophilic performance | |
CN108785749B (en) | A kind of superhydrophilic coating with catalytic NO long-term stable release function and preparation method thereof | |
CN101703813B (en) | Method for constructing anti-blood coagulation blood vessel scaffold by utilizing endogenous NO donor | |
CN114634763B (en) | A kind of cross-linked material with protein coating and preparation method thereof | |
CN101130114A (en) | Biocompatible surface coating for implantable medical devices and coating method thereof | |
US20170224876A1 (en) | Article coatings including oligomerized polyphenol layer and biological methods of use | |
CN103330960A (en) | Preparation method of coating having endothelium bionic function | |
CN103191469A (en) | Method for preparing coating carrying growth factor on surface of bone injury repair material | |
CN108686267B (en) | A kind of coating with anti-coagulation, anti-inflammatory and anti-proliferation functions and preparation method thereof | |
CN102698322B (en) | Preparation method of biomedical materials of multiclass functional group rich in amino group, carboxyl group and benzoquinonyl group | |
CN108969805A (en) | A kind of anticoagulation hydrogel coating and preparation method thereof being catalyzed nitric oxide releasing | |
CN101361988A (en) | A kind of preparation method of vascular stent or heart valve surface coating with good biocompatibility | |
CN114634762A (en) | Metal ion mediated protein coating, preparation method and application thereof | |
Ye et al. | Covalent surface modification of a titanium alloy with a phosphorylcholine‐containing copolymer for reduced thrombogenicity in cardiovascular devices | |
Li et al. | Coimmobilization of heparin/fibronectin mixture on titanium surfaces and their blood compatibility | |
CN103721300A (en) | Anticoagulation coating material and preparation method thereof | |
CN114618024B (en) | Endothelial function bionic material, preparation method and application thereof | |
US20160074563A1 (en) | Medical devices with reduced thrombogenicity | |
CN114632192B (en) | Strontium-phenol chelate self-assembled coating material, its preparation method and application | |
Yu et al. | The biofunctionalization of titanium nanotube with chitosan/genipin heparin hydrogel and the controlled release of IL-4 for anti-coagulation and anti-thrombus through accelerating endothelialization | |
WO2006038866A1 (en) | Improved coating comprising a bioadhesive polyphenolic protein derived from a byssus-forming mussel | |
CN110152064A (en) | A kind of heart valve modified by hydrophilic composite network laminate and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |